Skip to main content

Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 16, 2016

Drug Name	Review Type	Class	Manufacturer
Prezcobix	New Drug Initial Review	HIV	Johnson & Johnson
Envarsus XR	New Drug Initial Review	Immunosupressant	Veloxis Pharmaceuticals
Nucala	New Drug Initial Review	Severe Asthma	Glaxo Smith Kline
Zomacton	New Drug Initial Review	Growth Hormone	Ferring Pharmaceuticals
Veltassa	New Drug Initial Review	Potassium Binder	Relypsa, Inc.
Zepatier	New Drug initial Review	Hepatitis C	Merck
Jadenu	New Drug Appeal	Iron Chelator	Novartis
Triumeq	New Drug Appeal	HIV	ViiV Healthcare
Kitabis	New Drug Appeal	Cystic Fibrosis	Pari Respiratory, Inc.
Invega Trinza	New Drug Appeal	Long Acting Antipsychotic	Johnson & Johnson